HI
OGN icon

Humankind Investments’s Organon & Co OGN Stock Holding History

Humankind Investments’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,672
Closed -$178K – 119
2025
Q3 		$178K Sell
16,672
-388
-2% -$3.81K 0.04% 149
2025
Q2 		$165K Buy
17,060
+5,748
+51% +$59.3K 0.04% 142
2025
Q1 		$168K Sell
11,312
-251
-2% -$3.86K 0.04% 140
2024
Q4 		$173K Buy
+11,563
New +$188K 0.04% 143
2023
Q1 		– Sell
-7,573
Closed -$212K – 122
2022
Q4 		$212K Buy
+7,573
New +$194K 0.09% 113

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Humankind Investments's OGN Position: Q4 2025 in Review

Humankind Investments sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 16,672 shares — an estimated $178K sold.

Humankind Investments first reported a position in OGN in Q4 2022 and held it in 5 quarters. The position peaked at $212K in Q4 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Humankind Investments reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 16,672 Organon & Co shares in Q4 2025, an estimated $178K.
  • Humankind Investments first reported a position in Organon & Co in Q4 2022 and held it in 5 quarters.
  • Humankind Investments's Organon & Co position peaked at $212K in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.